Načítá se...
Cost-effectiveness of second curettage for treatment of low-risk non-metastatic gestational trophoblastic neoplasia
OBJECTIVE: Low-risk non-metastatic gestational trophoblastic neoplasia (GTN) has been treated with single agent chemotherapy, but second curettage is emerging as an alternative strategy with reported cure rates of 40%. We sought to estimate the cost-effectiveness of second curettage as the first lin...
Uloženo v:
| Vydáno v: | Gynecol Oncol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7293571/ https://ncbi.nlm.nih.gov/pubmed/32276791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2020.03.029 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|